Articles

What implications will these have on the pharma supply chain?

Trump Imposes Trade Tariffs on Canada, Mexico, and China

Videos

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, describes the highlights of a recent pharma supply chain security and visibility report that his company released.

Analyzing Supply Chain Complexities 

Celltrion’s Avtozma has been indicated for the treatment of giant cell arteritis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis, systemic juvenile idiopathic arthritis, and COVID-19—in the same dosages and formulations as its tocilizumab reference product. 

FDA Approves Actemra Biosimilar

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld value & access advisor for Schoonveld Advisory and author of The Price of Global Health, previews his upcoming February column.

The Rundown on Rebates

The latest news for pharma industry insiders.

Pharma Pulse 1/31/25: The Future of Fertility, Insights From American Oncology Network & more

Can monitoring these dispensed Rxs via online search behavior help predict future GLP-1 use in the United States?

Determining the Correlation Between Obesity Management Drug Dispensed Prescriptions and Online Search Behavior

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, value & access advisor for Schoonveld Advisory and author of The Price of Global Health, comments on the future implications of the latest CMS drug price negotiations.

What Round II of Medicare Part D Drug Prices Signify for the Pharma Industry

The 7,000 square-foot GMP facility will provide formulation development support, along with analytical testing services. 

Upperton Pharma Solutions Finalizes Construction of Sterile Manufacturing Plant

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, outlines the technological obstacles that lie ahead for the industry this year.

Challenges Facing Pharma Supply Chains

A study explores dual-enrollment in these plans—compared to other Medicare Advantage plans— impacts North Carolina’s Medicaid fee-for-service spending.

News